Outcomes After Unified Versus Standard GDM Diagnosis

NANot yet recruitingINTERVENTIONAL
Enrollment

2,650

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2027

Conditions
Gestational DiabetesDiagnosisPregnancy
Interventions
DIAGNOSTIC_TEST

NPRP criteria

Under the NPRP criterion, the plasma glucose level at each time point (TP1, TP2, and TP3) is multiplied by its weight (Doi et al. 2022), and the sum of these products yields the unified Doi's Weighted Average Glucose (dwAG) value for each woman. The dwAG is then categorized into four groups: a dwAG of 6.8 or lower, \>6.8 to ≤7.5, \>7.5 to ≤8.6, and above 8.6 mmol/L, indicating normal gestational glycemia (NGG), impaired gestational glycemia (IGG), gestational diabetes mellitus (GDM), and high-risk gestational diabetes mellitus (hGDM), respectively (Doi et al. 2022).

DIAGNOSTIC_TEST

IADPSG criteria

The IADPSG criteria define GDM as any one of the three-time points above specific thresholds: the time point prior to glucose ingestion (TP1) is considered abnormal when the fasting plasma glucose (FPG) value is ≥ 5.1 mmol/L, the 1-hour time-point after glucose ingestion (TP2) is considered abnormal when the value is ≥ 10 mmol/L, and the 2-hour time-point after glucose ingestion (TP3) is considered abnormal when the Post-Load Plasma Glucose levels are ≥ 8.5 mmol/L (Metzger et al. 2010). Put simply, meeting any one of these cut-offs results in a GDM diagnosis, regardless of whether the other time points show normal values or not (Metzger et al. 2010).

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hamad Medical Corporation

INDUSTRY

lead

Qatar University

OTHER

NCT06401629 - Outcomes After Unified Versus Standard GDM Diagnosis | Biotech Hunter | Biotech Hunter